High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018

Date: February 11, 2014
Pages: 151
Price:
US$ 4,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: H827A1BFD70EN
Leaflet:

Download PDF Leaflet

High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018
The global high content screening market is a technology-driven market and is marked by the ‘Threat of Obsolescence,’ wherein technologies as well as their adoption by end users changes very rapidly. Pharmaceutical and biotechnology companies as well as academic and government institutes are increasingly focusing on using high content screening as a powerful research tool in drug discovery. The high content screening software market is the fastest-growing segment in the high content screening market. In high content screening, the accuracy of the results obtained depends on image analysis and data management software. In recent years, enhanced image analysis and data management solutions have been introduced, but there is scope for these solutions to be further improvised to provide improved results. Many of the key players in the high content screening instruments market are collaborating with software companies to offer products with better software. For instance, in November 2010, PerkinElmer collaborated with Glencoe Software, Inc. to integrate Columbus Scope, a cellular imaging software solution for microscopy. With the data sharing facility, Columbus Scope helps in data management in high content screening.

In the coming years, Asian countries are expected to witness a high growth. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets for high content screening. This region offers a high growth potential as compared to mature markets such as the U.S. Growth in the Asian market is spurred by government support for the development of innovative screening technologies and rising demand for outsourcing of drug discovery services. For instance, in September 2013, Global Health Innovative Technology Fund (GHIT Fund), granted $5.7 million to six global partnerships to support the R&D activities of these partnerships in the area of various infectious diseases like tuberculosis, malaria, and Chagas disease. Such fundings are expected to boost the growth of the high content screening market.

The global high content screening market is competitive and all the existing players in this market are engaged in developing new and advanced products to maintain their market shares.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios and services offered by the top players in the high content screening market. The report analyzes the high content screening market by application across geographies

Product Development/Innovation: Detailed insights on research and development activities and new product launches in the high content screening market

Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes promising applications of the high content screening market by product across geographies

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the high content screening market

Competitive Assessment: In-depth assessment of market shares, strategies, products and services, and distribution networks in the high content screening market
1 INTRODUCTION

1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
  1.6.1 Market Size Estimation
  1.6.2 Market Crackdown and Data Triangulation
  1.6.3 Market Share
  1.6.4 Key Data Points From Primary Sources
  1.6.5 Key Data Points From Secondary Sources

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW

3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
  3.3.1 Drivers
    3.3.1.1 Need For Determining Level of Toxicity in the Early Stages of Drug Discovery
    3.3.1.2 Government Funding and Venture Capital Investments in Cell-Based Research Will Drive the Market Growth
    3.3.1.3 Introduction of Enhanced Informatics Solutions and Improved Image Analysis Instruments
  3.3.2 Restraints
    3.3.2.1 High Cost of High Content Screening Systems May Hinder the Market Growth
  3.3.3 Opportunities
    3.3.3.1 Contract Research Organizations Have Significant Opportunities To Provide HCS Services
    3.3.3.2 Adoption of High Content Screening For Primary Screening
    3.3.3.3 Application of High Content Screening in Personalized Medicine
    3.3.3.4 Collaborations To Increase Innovation in the HCS Market
  3.3.4 Challenges
    3.3.4.1 Shortage of Knowledgeable and Skilled Professionals For High Content Screening
3.4 Market Share Analysis

4 BY PRODUCT TYPE

4.1 Introduction
4.2 Instruments
  4.2.1 Cell Imaging and Analysis Systems
  4.2.2 Flow Cytometers
4.3 Consumables
  4.3.1 Reagents & Assay Kits
  4.3.2 Microplates
  4.3.3 Other Consumables
4.4 Software
4.5 Services

5 BY APPLICATION

5.1 Introduction
  5.1.1 Target Identification and Validation
  5.1.2 Primary Screening and Secondary Screening
  5.1.3 Toxicity Studies
  5.1.4 Compound Profiling
  5.1.5 Other Applications

6 BY END USERS

6.1 Pharmaceutical and Biotechnology Companies
6.2 Academia and Government Institutes
6.3 Contract Research Organizations (CRO)

7 GEOGRAPHIC ANALYSIS

7.1 Introduction
7.2 North America
7.3 Europe
7.4 Asia
7.5 ROW

8 COMPETITIVE LANDSCAPE

8.1 Introduction
8.2 New Product Launch
8.3 Expansions
8.4 Agreements, Collabarations, Partnerships
8.5 Acquisitions

9 COMPANY PROFILES (OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)

9.1 Becton, Dickinson and Company
9.2 Cell Signaling Technology, Inc.
9.3 Danaher Corporation
9.4 Ge Healthcare (Subsidiary of General Electric Company)
9.5 Genedata Ag
9.6 Merck Kgaa
9.7 Perkinelmer, Inc.
9.8 thermo Fisher Scientific, Inc.
9.9 Thorlabs, Inc.
9.10 Yokogawa Electric Corporation (Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.)

LIST OF TABLES

Table 1 Global Market, By Product Type, 2011–2018 ($Million)
Table 2 HCS Products Market, By Geography, 2011–2018 ($Million)
Table 3 The Global High Content Screening Instruments Market, By Type, 2011–2018 ($Million)
Table 4 HCS Instruments Market, By Geography, 2011–2018 ($Million)
Table 5 Cell Imaging and Analysis HCS Systems Market, By Geography, 2011–2018 ($Million)
Table 6 HCS Flow Cytometers Market, By Geography, 2011–2018 ($Million)
Table 7 Global HCS Consumables Market, By Type, 2011–2018 ($Million)
Table 8 HCS Consumables Market, By Geography, 2011–2018 ($Million)
Table 9 HCS Reagents and Assay Kits Market, By Geography, 2011–2018 ($Million)
Table 10 HCS Microplates Market, By Geography, 2011–2018 ($Million)
Table 11 HCS Other Consumables Market, By Geography, 2011–2018 ($Million)
Table 12 HCS Software Market, By Geography, 2011–2018 ($Million)
Table 13 HCS Services Market, By Geography, 2011–2018 ($Million)
Table 14 Global HCS Applications Market, By Type, 2011–2018 ($Million)
Table 15 HCS Applications Market, By Geography, 2011–2018 ($Million)
Table 16 HCS Target Identification and Validation Market, By Geography, 2011-2018 ($Million)
Table 17 HCS Primary and Secondary Screening Market, By Geography, 2011–2018 ($Million)
Table 18 HCS Toxicity Studies Market, By Geography, 2011–2018 ($Million)
Table 19 HCS Compound Profiling Market, By Geography, 2011–2018 ($Million)
Table 20 HCS Other Applications Market, By Geography, 2011–2018 ($Million)
Table 21 Global Market, By End User, 2011–2018 ($Million)
Table 22 HCS End Users Market, By Geography ($Million)
Table 23 Pharmaceutical and Biotechnology Companies HCS Market, By Geography, 2011–2018 ($Million)
Table 24 Academia and Government Institutes HCS Market, By Geography, 2011–2018 ($Million)
Table 25 Contract Research Organization HCS Market, By Geography, 2011-2018 ($Million)
Table 26 HCS Product Market, By Geography, 2011–2018 ($Million)
Table 27 North America: Market, By Product Type, 2011–2018 ($Million)
Table 28 North America: HCS Instruments Market, By Type, 2011–2018 ($Million)
Table 29 North America: HCS Consumables Market, By Type, 2011–2018 ($Million)
Table 30 North America: Market, By Application Type, 2011–2018 ($Millions)
Table 31 North America: Market, By End User, 2011–2018 ($Million)
Table 32 Europe: Market, By Product Type, 2011–2018 ($Million)
Table 33 Europe: HCS Instruments Market, By Type, 2011–2018 ($Million)
Table 34 Europe: HCS Consumables Market, By Type, 2011–2018 ($Million)
Table 35 Europe: Market, By Application Type, 2011–2018 ($Million)
Table 36 Europe: Market, By End User, 2011–2018 ($Million)
Table 37 Asia: Market, By Product Type, 2011–2018 ($Million)
Table 38 Asia: HCS Instruments Market, By Type, 2011–2018 ($Million)
Table 39 Asia: HCS Consumables Market, By Type, 2011–2018 ($Million)
Table 40 Asia: Market, By Application, 2011–2018 ($Million)
Table 41 Asia: Market, By End User, 2011–2018 ($Million)
Table 42 ROW: Market, By Product Type, 2011–2018 ($Million)
Table 43 ROW: HCS Instruments Market, By Type, 2011–2018 ($Million)
Table 44 ROW: HCS Consumables Market, By Type, 2011–2018 ($Million)
Table 45 ROW: Market, By Application, 2011–2018 ($Million)
Table 46 ROW: Market, By End User, 2011–2018 ($Million)
Table 47 New Product Launch, 2011–2013
Table 48 Expansions, 2011–2013
Table 49 Agreements, Partnerships, Collabarations, 2011–2013
Table 50 Acquisitions, 2011–2013

LIST OF FIGURES

Figure 1 Forecast Model
Figure 2 Market Size Estimation Methodology
Figure 3 Market Crackdown & Data Triangulation Methodology For the HCS Market
Figure 4 Global Market, By Product, 2013–2018 ($Million)
Figure 5 HCS Market, By Geography, 2013–2018 ($Million)
Figure 6 Market Segmentation
Figure 7 Market Dynamics
Figure 8 Global HCS Instruments Market Share, By Key Players, 2013
Figure 9 HCS Products Market, By Geography, 2013
Figure 10 Key Growth Strategies, HCS Market, 2011–2013

Ask Your Question

High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: